by DMCBiotech | May 4, 2020 | DMC Press Releases, News
04 May 2020 – DMC Biotechnologies welcomes Doug Cameron to the team as an Independent Board member. He joins the Board effective immediately to support DMC’s growth as it moves to commercialization. Doug brings more than 30 years of experience in the biotech industry...
by DMCBiotech | Feb 6, 2020 | DMC Press Releases, News
06 February 2020 – DMC Biotechnologies has successfully produced its lead product, L-alanine at pilot scale. Commercial key performance metrics were achieved and performance from the bench scale was also demonstrated at 3m3 scale fermentation and for each of the...
by DMCBiotech | Dec 16, 2019 | DMC Press Releases, News
16 December 2019 – DMC Biotechnologies has completed additional closings as part of the Company’s Series A funding round which was led by Sofinnova Partners. Boulder Ventures VII L.P. (BV) and SCG have now joined the Series A round bringing the total close to $11.3...
by DMCBiotech | Dec 9, 2019 | DMC Press Releases, News
09 December 2019 – An essential patent has been allowed for DMC Biotechnologies’ Dynamic Metabolic Control technology. Patent number PCT/US2015/035306 with the title ‘Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves’ has...
by DMCBiotech | Nov 18, 2019 | DMC Press Releases, News
18 November 2019 – The US National Science Foundation (NSF) has awarded an additional $500,000 to DMC through its Small Business Innovation Research (SBIR) Phase IIB program. This is in addition to over $960,000 previously awarded to DMC by NSF through the SBIR Phase...
